The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
Positioning early cell therapy programs for clinical success: Insights to mitigate risk and ensure GMP readiness
Webinar On Demand
Cell therapies have the potential to revolutionize treatment modalities for a wide range of conditions, from cardiovascular diseases to neurological disorders and many others. But their potential is often tempered by the myriad challenges of transitioning these innovations from R&D laboratories to real-world clinical applications.
Our recent webinar explored key considerations for early-phase cell therapy developers, including evolving regulatory guidelines and common manufacturing issues. Additionally, it covered the essentials of orchestrating a successful cell therapy clinical trial, showcasing the challenges and innovative solutions that today’s sponsors are likely to encounter.
In addition to these topics, specific webinar key takeaways included:
- Opportunities for a more streamlined, patient-centric approach to cell therapy clinical trials
- Strategies to navigate regulatory hurdles and maximize the impact of meetings with regulators
- Best practices to address challenges in cell therapy process development and manufacturing
- How an integrated CRO/CDMO can help simplify the value chain and improve patient centricity